PhotonPharma receives FDA clearance for ovarian cancer vaccine trial

PhotonPharma receives FDA clearance for ovarian cancer vaccine trial

Source: 
Clinical Trials Arena
snippet: 

PhotonPharma has received clearance from the US FDA to commence a Phase I trial of its vaccine, Innocell, to treat ovarian cancer.